Peter Huffman
Optometrist · Dallas, GANPI 1679759849
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (42.1%), speaking fees and gifts — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Coopervision Inc. at 50.2% of the total. Reporting peaked in 2019 at $1,687 and has fallen 84.9% since, to $254 in 2025.
Across 56 payments — averaging $63.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$2K
- Alcon$580
- The Walman Optical Company$480
- Bausch & Lomb Americas Inc.$208
- Glaukos Corporation$194
- Bausch & Lomb, A Division Of Bausch Health US, LLC$103
- plus $217 from 5 others
What the payments were for
- Speaking & faculty fees$1,50042%
- Food & beverage$1,50642%
- Gifts$48013%
- Entertainment$913%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 10 | $1,796 |
| Alcon | 29 | $580 |
| The Walman Optical Company | 1 | $480 |
| Bausch & Lomb Americas Inc. | 4 | $208 |
| Glaukos Corporation | 2 | $194 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $103 |
| Optos, Inc. | 1 | $91 |
| Johnson & Johnson Vision Care, Inc. | 3 | $47 |
| Dompe US, Inc. | 2 | $36 |
| Visioneering Technologies, Inc. | 2 | $27 |
| Menicon America Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Clariti Contact Lens$1,500
- Precision 1$149
- MiSight Contact Lens$129
- KXL System$123
- Photrexa$123
- INFUSE$103
- LOTEMAX SM$101
- VYZULTA$101
How this compares
$3,578 in reported general payments places this provider in the 85th percentile of 1,285 optometrist providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CombiganBrimonidine Tartrate/Timolol | 11 | $2,813 |
| Latanoprost | 21 | $228 |
| Timolol Maleate | 16 | $99 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Dallas
- Joshua JohnstonAtlanta$993K
- John WomackCanton$931K
- Naheed AhmadRoswell$296K
- Scott MoscowRoswell$278K
- Stephen SummerowPerry$222K
- Janelle DavisonSmyrna$199K
- Keyle BrownDawsonville$182K
- Nacondus GambleFort Stewart$175K
- Amber ZaunbrecherAtlanta$99K
- Jeffrey CofieWarner Robins$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.